- Home
- CNFR vs BFRI Comparison
CNFR vs BFRI Comparison
Compare CNFR & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNFR
- BFRI
- Stock Information
- Founded
- CNFR 2009
- BFRI 1997
- Country
- CNFR United States
- BFRI United States
- Employees
- CNFR N/A
- BFRI N/A
- Industry
- CNFR Property-Casualty Insurers
- BFRI Biotechnology: Pharmaceutical Preparations
- Sector
- CNFR Finance
- BFRI Health Care
- Exchange
- CNFR Nasdaq
- BFRI Nasdaq
- Market Cap
- CNFR 9.4M
- BFRI 7.9M
- IPO Year
- CNFR 2015
- BFRI 2021
- Fundamental
- Price
- CNFR $0.84
- BFRI $0.92
- Analyst Decision
- CNFR
- BFRI Strong Buy
- Analyst Count
- CNFR 0
- BFRI 1
- Target Price
- CNFR N/A
- BFRI $2.75
- AVG Volume (30 Days)
- CNFR 5.2K
- BFRI 92.4K
- Earning Date
- CNFR 08-19-2025
- BFRI 08-13-2025
- Dividend Yield
- CNFR N/A
- BFRI N/A
- EPS Growth
- CNFR N/A
- BFRI N/A
- EPS
- CNFR 1.96
- BFRI N/A
- Revenue
- CNFR $64,021,000.00
- BFRI $37,997,000.00
- Revenue This Year
- CNFR $25.91
- BFRI $11.75
- Revenue Next Year
- CNFR N/A
- BFRI $17.09
- P/E Ratio
- CNFR $0.42
- BFRI N/A
- Revenue Growth
- CNFR N/A
- BFRI 14.28
- 52 Week Low
- CNFR $0.42
- BFRI $0.54
- 52 Week High
- CNFR $1.91
- BFRI $2.22
- Technical
- Relative Strength Index (RSI)
- CNFR 51.71
- BFRI 48.84
- Support Level
- CNFR $0.73
- BFRI $0.97
- Resistance Level
- CNFR $0.93
- BFRI $1.14
- Average True Range (ATR)
- CNFR 0.08
- BFRI 0.10
- MACD
- CNFR -0.01
- BFRI -0.02
- Stochastic Oscillator
- CNFR 49.74
- BFRI 12.10
About CNFR Conifer Holdings Inc.
Conifer Holdings Inc is an insurance holding company. The company markets and services the product offerings of the company through specialty personal insurance business lines. The company offers insurance products in Texas, Illinois, and Indiana for homeowners lines and Nevada and Michigan for other lines. The revenues of the company are derived from premiums earned from insurance operations.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.